Using receiver operating characteristic (ROC) curve analysis, we identified DLAT, DLD, FDX1, PDHA1, PDHB, GLRX5, HSPA1A, and LIAS as having strong diagnostic potential, suggesting their utility as biomarkers for PD treatment. This evidence concerns the gene FDX1 and Parkinson disease.